Literature DB >> 23164383

Pathological concordance and surgical outcomes of sporadic synchronous unilateral multifocal renal masses treated with partial nephrectomy.

Jay Simhan1, Daniel J Canter, Steven N Sterious, Marc C Smaldone, Kevin J Tsai, Tianyu Li, Rosalia Viterbo, David Y T Chen, Richard E Greenberg, Alexander Kutikov, Robert G Uzzo.   

Abstract

PURPOSE: Patients with unilateral synchronous multifocal renal masses represent a unique population with renal cell carcinoma. While pathological concordance rates have been studied for bilateral cases, limited data exist on unilateral multifocal disease. We characterized pathological concordance rates in this population and evaluated the outcomes of nephron preservation.
MATERIALS AND METHODS: Patients who underwent surgery from 2000 to 2012 for unilateral synchronous multifocal renal masses were identified from a prospectively maintained database. Demographic, surgical and pathological outcomes of this cohort were analyzed. Malignant concordance rates were defined as agreement of all malignant tumor types in a single renal unit. Histological concordance was defined as agreement of all resected mass histologies, eg all clear cell carcinomas. Nuclear grade was considered concordant if all tumors excised were low (Fuhrman 1 or 2, type 1) or high (Fuhrman 3 or 4, type 2) grade.
RESULTS: Using our institutional database of 2,569 patients with renal tumors we identified 97 with unilateral synchronous multifocal renal masses. Malignant and benign concordance rates were 77.2% and 48.6%, and histological and grade concordance rates were 58.8% and 51.5%, respectively. In this cohort we identified 76 patients (76.3% male) with a median age of 62.5 years who had a total of 241 unilateral synchronous multifocal renal masses and underwent nephron sparing surgery. Median mass size was 2.0 cm (IQR 1.1-3.1), there was a median of 3 tumors per patient and median followup was 24 months (IQR 13-40). Identified renal cell carcinoma histologies included clear cell in 49.4% of cases, papillary in 33.5%, mixed in 4.5% and chromophobe in 2.8%.
CONCLUSIONS: In what is to our knowledge the largest published report of unilateral synchronous multifocal renal masses we document low pathological concordance rates. As such, percutaneous biopsy of a single renal mass in these patients may not help inform treatment decisions. Nephron sparing surgery may be performed with acceptable oncological and functional results in patients with unilateral synchronous multifocal renal masses.
Copyright © 2013 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23164383     DOI: 10.1016/j.juro.2012.08.092

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  12 in total

1.  Partial and Radical Nephrectomy for Unilateral Synchronous Multifocal Renal Cortical Tumors.

Authors:  Roy Mano; Matthew Kent; Yaniv Larish; Andrew G Winer; Michael S Chevinsky; Abraham Ari Hakimi; Itay A Sternberg; Daniel D Sjoberg; Paul Russo
Journal:  Urology       Date:  2015-04-11       Impact factor: 2.649

Review 2.  The role of minimally invasive surgery in multifocal renal cell carcinoma.

Authors:  Serge Ginzburg; Robert G Uzzo; Alexander Kutikov
Journal:  Curr Urol Rep       Date:  2012-06       Impact factor: 3.092

3.  The accuracy of renal tumor biopsy: analysis from a national prospective study.

Authors:  J C Bernhard; P Bigot; G Pignot; H Baumert; L Zini; H Lang; M Crepel; P Monod; L Salomon; L Bellec; M Roupret; M Schneider; E Xylinas; P Paparel; F Bruyere; J Berger; J P Ansieau; P Gimel; F Salome; C Castagnola; C Pfister; J M Legraverend; M O Timsit; L Le Pellec; J L Auberget; E Rolland; R Mallet; A Mejean; J J Patard
Journal:  World J Urol       Date:  2014-11-06       Impact factor: 4.226

4.  Ipsilateral synchronous papillary and clear renal cell carcinoma: A case report and review of literature.

Authors:  Jing Yin; Mo Zheng
Journal:  World J Clin Cases       Date:  2022-06-06       Impact factor: 1.534

5.  Oncologic outcomes of nephron-sparing surgery in patients with T1 multifocal renal cell carcinoma.

Authors:  G Li; D Zhu; H Gao; H Chen; Y Li; Y Niu
Journal:  Clin Transl Oncol       Date:  2018-11-15       Impact factor: 3.405

Review 6.  Natural history of untreated kidney cancer.

Authors:  Kristen McAlpine; Antonio Finelli
Journal:  World J Urol       Date:  2021-02-16       Impact factor: 4.226

7.  Coexisting papillary and clear renal cell carcinoma in the same kidney.

Authors:  Murat Ustuner; Busra Yaprak; Kerem Teke; Seyfettin Ciftci; Mucahit Kart; Kursat Yildiz; Melih Culha
Journal:  Case Rep Urol       Date:  2014-08-10

Review 8.  Heterogeneity and renal mass biopsy: a review of its role and reliability.

Authors:  Jeffrey J Tomaszewski; Robert G Uzzo; Marc C Smaldone
Journal:  Cancer Biol Med       Date:  2014-09       Impact factor: 4.248

9.  Ipsilateral synchronous clear and papillary renal cell carcinoma: A case report and review of the literature.

Authors:  Muna Alhusban; Sohaib Alhamss; Bayan Alzumaili; Ali Al-Daghmin
Journal:  Urol Case Rep       Date:  2017-11-23

10.  The Clinicopathologic and Molecular Landscape of Clear Cell Papillary Renal Cell Carcinoma: Implications in Diagnosis and Management.

Authors:  Stanley Weng; Renzo G DiNatale; Andrew Silagy; Roy Mano; Kyrollis Attalla; Mahyar Kashani; Kate Weiss; Nicole E Benfante; Andrew G Winer; Jonathan A Coleman; Victor E Reuter; Paul Russo; Ed Reznik; Satish K Tickoo; A Ari Hakimi
Journal:  Eur Urol       Date:  2020-10-10       Impact factor: 20.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.